“…Fungal β-glucans, such as lentinan from L. edodes (shiitake), schizophyllan from S. commune (split gill), zymosan from S. cereviase (baker's yeast), pleuran from P. ostreatus (oyster), and ganoderan from G. lucidum (reishii), have also been extensively studied due to the human immune system's ability to recognize them, promoting immune stimulation, antibacterial, antitumor, anticancer, and antioxidant properties [92][93][94][95]. These findings, coupled with the varying chitin, chitosan, and polysaccharide profiles of the over 5.1 million species of fungi in existence [96] and recent advances in fungal material technology [7,14,17,[97][98][99][100][101], suggest that fungi-derived wound treatments warrant further investigation. In particular, the native chitin-β-glucan composite architecture of fungal chitin could be utilized to achieve scaffolds exceeding the mechanical performance of crustacean chitin [17] and novel antibacterial properties resulting from composite dressings incorporating naturally generated complexes of fungal chitin, chitosan, β-glucans, and exopolysaccharides could pave the way for new low-cost, natural, and mass-producible dressing technologies.…”